Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKM120 in Metastatic Head and Neck Cancer
NCT01737450Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Jan 2013
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of buparlisib in head and neck squamous cell carcinoma (HNSCC), sponsored by Centre Léon Bérard. Started Jan 2013; status: completed.
02
Drugs
buparlisib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01737450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737450.